STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Clinical trials for STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to tame tough thyroid cancer
Disease control OngoingThis study is testing whether a combination of targeted drugs, with or without an immunotherapy drug, can help control advanced thyroid cancer that has spread and no longer responds to standard radioactive iodine treatment. It is for patients whose cancer has a specific genetic c…
Matched conditions: STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Apr 04, 2026 03:50 UTC
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC